[ad_1] The worldwide impact of the COVID-19 pandemic has led to an unprecedented effort to develop vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a timeframe never imagined before. . Although some vaccines have started to be administered on a large scale, scientists and governments are facing …
Read More »Particulate matter levels can play a significant role in the transmission of SARS-CoV-2
[ad_1] Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome agent coronavirus 2 (SARS-CoV-2), has infected more than 63.93 million people and caused the deaths of over 1.49 millions around the world. The virus is mainly spread through respiratory or aerosol droplets that remain suspended in the air …
Read More »Deletion mutations of SARS-CoV-2 may have attenuated infectivity in some strains
[ad_1] Caused by the severe acute respiratory syndrome agent coronavirus 2 (SARS-CoV-2), the 2019 coronavirus disease (COVID-19) pandemic has reached over 191 countries and infected more than 63.98 million people. Scientists around the world are racing to better understand the virus, how it is transmitted and how it affects the …
Read More »It now appears that COVID-19 was already in the United States in December 2019
[ad_1] COVID-19 may have already arrived in the United States in December 2019, before the disease was even identified in China, a new study suggests. Researchers in the study, from the Centers for Disease Control and Prevention (CDC), analyzed more than 7,000 blood donations collected by the American Red Cross …
Read More »The repurposed mouse model sheds light on the spectrum of symptoms of COVID-19 disease
[ad_1] A repurposed mouse model can develop symptoms of both severe COVID-19 (lung damage, blood clots, abnormal blood vessels, and death) as well as milder diseases, including loss of smell, according to a recent study published by the University of London. ‘Iowa in Nature. The study also showed that convalescent …
Read More »PTC299 inhibits SARS-CoV-2 replication and suppresses inflammatory cytokine production
[ad_1] The 2019 coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a serious global public health crisis. To date, the virus has infected 63.75 million people and has caused the deaths of over 1.47 million worldwide, showing that there is an urgent …
Read More »How does COVID-19 affect people living with HIV?
[ad_1] Most research indicates that people living with HIV are not more likely to contract SARS-CoV-2, the coronavirus that causes COVID-19, nor are they more likely to develop severe COVID-19 or die. because of it. According to the World Health Organization, “At present, there is no evidence that the risk …
Read More »Fibromyalgia during COVID-19, anxiety and pain
[ad_1] Early research on the impact of the COVID-19 pandemic has found persistent related anxiety in the general population. Researchers in the UK speculated that this anxiety would be associated with increased pain in chronic pain patients diagnosed with fibromyalgia (FM). Fibromyalgia affects approximately 2% of the world population. A …
Read More »Marinomed designs clinical trial with Carragelose nasal spray as a prophylaxis for COVID-19
[ad_1] Marinomed Biotech AG, a globally operating biopharmaceutical company, is pleased to announce today that Swansea University Medical School is planning a clinical trial with Iota / kappa-carrageenan nasal spray as a COVID-19 prophylaxis for healthcare professionals (ICE-COVID) . The investigator-initiated study in Swansea will recruit 480 healthcare professionals who …
Read More »Researchers reveal how SARS-CoV-2 reaches the brain
[ad_1] Using post mortem tissue samples, a team of researchers from Charité – Universitätsmedizin Berlin has studied the mechanisms by which the novel coronavirus can reach the brains of COVID-19 patients and how the immune system responds to the virus once it does. The results, which show that SARS-CoV-2 enters …
Read More »